Happy Monday folks! Looking for the latest headline news from the genomics world (and beyond)? Week in Brief has you covered.
Breast cancer has been in the news this week…
Researchers have mapped distinct cell communities within metastatic breast cancers, uncovering cellular interactions that drive cancer spread. This detailed atlas of single-cell communities could lead to more effective, targeted treatments for metastatic disease (Nature Medicine).
An extensive analysis of breast cancer cells has revealed cellular diversity within tumours, providing a more nuanced understanding of breast cancer types. This research, published this week in a pair of papers, could help personalise treatments for better outcomes (JBC, PLoS Biology).
A combination of genome sequencing and AI analysis has revealed intricate details about the genetic variants involved in breast cancer onset. The work also shed light on previously overlooked pathways contributing to cancer prognosis (Briefings in Bioinformatics).
Other cancer breakthroughs have also been in the spotlight…
A newly developed drug has shown promise in triggering rapid cancer cell death in experimental models. This drug reactivates the apoptosis cascade in tumour cells, preventing them from proliferating (Nature Cancer).
Scientists have identified a cellular ‘shield’ surrounding lung tumours, which protects them from some therapies. Understanding these protective cells could lead to strategies that enhance treatment effectiveness in lung cancer (Science Advances).
How can we gain a better understanding of genetic disorders?
A large genomic database from Latin America has been established, offering valuable data on the genetic diversity of the region. This resource could improve research into region-specific diseases and medical treatments (Cell Genomics).
A novel method has been developed to analyse the genetic mutations that underlie many rare and complex diseases. This approach could be key to understanding and tackling genetically driven disorders (Physiological Genomics).
Genomic sequencing can provided key insights into mitochondrial diseases, according to a new study. This finding could improve diagnostics and highlighting potential therapeutic avenues for affected patients (Genetics in Medicine).
What else has gone on this week?
A new single-cell search engine has been developed using machine learning to accelerate cell annotation. This tool promises to make cellular analysis faster and more accurate, aiding researchers across various fields, and is now available in beta mode (Broad Institute).
A new study has provided a comprehensive look into blood cell dynamics post-stem cell transplant. These insights may improve success rates in treating blood disorders (Nature).
A combined in vivo and in vitro approach has shown the therapeutic potential of non-coding RNA in pathological cardiac hypertrophy. These insights are a step toward creating RNA-based therapies for challenging conditions (Frontiers of Medicine).
A study has linked mammalian longevity to lower cancer risks through genetic markers in naked mole rats. These findings may inspire new strategies for increasing lifespan and reducing cancer susceptibility (PNAS).
Check out last week’s Week in Brief here.
